BSECompany Update3d ago · 11 Aug 2026, 04:01 pm

AS PER THE DOCUMENT ATTACHED

Continental Chemicals Ltd · 506935

✦ AI SummaryFundraise

Continental Chemicals Ltd has submitted a statement of deviation and variation in the utilization of funds raised through a preferential issue for the quarter ended June 2026, as per Regulation 32 of SEBI (LODR) Regulations, 2015.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk2/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Continental Chemicals Ltd - 506935 - STATEMENT OF DEVIATION AND VARIATION FOR JUNE 2026

Attachments (1)

📄

eb310f33-8a9d-4c24-be68-ddd4a8523a04.pdf

pdf

Download →
View document text
ondinental b Tel. :91-120-2423316 E-mail : info@continentalsoft.com : nke@eontinentalsoft.com @hgm i t al5 Zfith Web : www.continentalchemicalsitd.com CIN : L24723UP1984PLCO14171 Regd. & Head Office : A-7, Sector-7, Noida:2013C1 (U.P.) India Date: 11.08.2026 General Manager, Bombay Stock Exchange Limited, Phiroze Jeejeebhoy Tower, Dalal Street, Fort Mumbai, Mabharashtra-400001 Scrip Code- 506935 ISIN- INE423K01015 Subject: Submission of Statement of Deviation under Regulation 32 of SEBI (LODR) Regulations, 2015 for the quarter ended 30™ June, 2026: Dear Sir, Pursuant to regulation 32 of SEBI (LODR) Regulations, 2015, please find attached Statement of deviation and variation of utilization of fund raised through preferential issue for the quarter ended 30% June, 2026. This is for your information and records. Thanking you, Your faithfully, For Continental Chemicals Limited Sakshi Dhawan ettty Sakshi Dhawan Company Secretary (Membership No: ACS 33279) Continental/ 14 Chemicals Lid Regd. & Head Office : A-7, Sector-7, Noida-201301 (U.P.) India < el. :91-120-2423316 E-mail : info@continentalsoft.com : nkc@continentalsoft.com Web : www.continentalchemicalsitd.com CIN :L24123UP1984PLC014111 GST No. : 09AAACC1412B2ZH Annexure-A Statement of Deviation / Variation in utilization of funds raised Continental Chemicals Name of listed entity Limited Preferential Issues Mode of Fund Raising Date of Raising Funds 14/10/2019 Amount Raised 1,62,50,000 Report filed for Quarter ended 30/06/2026 Monitoring Agency Not Applicable Monitoring Agency Name, if Not Applicable applicable Is there a Deviation / Variation in | No use of funds raised If yes, whether the same is Not Applicable pursuant to change in terms ofa contract or objects, which was approved by the shareholders If Yes, Date of shareholder Not Applicable Approval Explanation for the Deviation / Not Applicable Variation Comments of the Audit Committee Reviewed and Approved after review by audit committee Comments of the auditors, if any Not Applicable Objects for which funds have been Company has required raised and where there has been a the funds for working deviation, in the following table capital Original Object Modified Object, if any O 1 rigina | M ieo dd if UF tu in ld is se d | oA fm ount Allocat | allocat Deviation/ ion ion, if Variation any for the quarter according applicable object Company has required the funds Not Applicable 1,62,50 | Not " 0 ,000 Applic for working capital able Page1of2 AN note below * Note: Please note that the funds have been fully utilized in the quarter ended 31/12/2023 Deviation or variation could mean: (a) Deviation in the objects or purposes for which the funds have been raised or (b) Deviation in the amount of funds actually utilized as against what was originally disclosed or (c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, Name of Signatory: Naresh Kumar Chibba Designation: Managing Director Date: 11.08.2026 Page 2 of 2